Femasys announces notices of intention to grant for two new european patent applications covering use of fembloc permanent birth control

European patents expand coverage for both essential components of fembloc for fallopian tube occlusion, resulting in non-surgical permanent contraception european patents expand coverage for both essential components of fembloc for fallopian tube occlusion, resulting in non-surgical permanent contraception
FEMY Ratings Summary
FEMY Quant Ranking